Results 21 to 30 of about 9,368 (211)

Idiopathic inflammatory myopathies and the lung

open access: yesEuropean Respiratory Review, 2015
Idiopathic inflammatory myositis (IIM) is a group of rare connective tissue diseases (CTDs) characterised by muscular and extramuscular signs, in which lung involvement is a challenging issue.
Jean-Christophe Lega   +5 more
doaj   +1 more source

Polymyositis and dermatomyositis: Disease spectrum and classification

open access: yesIndian Journal of Dermatology, 2012
Muscle inflammation and weakness are the key features of idiopathic inflammatory myopathies (IIMs). In addition IIMs are frequently associated with cutaneous and pulmonary involvement. In clinical practice the three common inflammatory myopathies we come
Siba P Raychaudhuri, Anupam Mitra
doaj   +1 more source

Predictors of cardiac involvement in idiopathic inflammatory myopathies

open access: yesFrontiers in Immunology, 2023
ObjectivesIdiopathic inflammatory myopathies (IIM) are a group of rare disorders that can affect the heart. This work aimed to find predictors of cardiac involvement in IIM.MethodsMulticenter, open cohort study, including patients registered in the IIM ...
Matilde Bandeira   +43 more
doaj   +1 more source

Clinical characteristics of patients with anti-TIF1-γ antibodies

open access: yesRheumatology, 2016
Objectives : Inflammatory myopathies are a group of idiopathic, heterogeneous systemic diseases affecting predominantly skeletal muscles, though they can also involve the skin and internal organs.
Anna Masiak   +3 more
doaj   +1 more source

POLYMYOSITIS/DERMATOMIOSITIS: DIFFERENTIAL DIAGNOSIS

open access: yesНаучно-практическая ревматология, 2016
The lecture considers the problem of rare systemic connective tissue diseases, such as idiopathic inflammatory myopathies (IIMs). It underlines the clinical and immunological heterogeneity of their subtypes, which defines therapeutic tactics and ...
O. A. Antelava
doaj   +1 more source

Polymyositis and dermatomyositis – challenges in diagnosis and management

open access: yesJournal of Translational Autoimmunity, 2019
Polymyositis (PM) and dermatomyositis (DM) are different disease subtypes of idiopathic inflammatory myopathies (IIMs). The main clinical features of PM and DM include progressive symmetric, predominantly proximal muscle weakness.
Shu-Han Yang   +2 more
doaj   +1 more source

Electrophysiological, structural, and functional disorders in patients with inflammatory cardiomyopathy secondary to inflammatory myopathy

open access: yesAnnals of Noninvasive Electrocardiology, 2022
Background Inflammatory cardiomyopathy (IC) is a syndrome with chronic myocarditis and cardiac remodeling. This study aimed to explore predicting factors of adverse outcomes in patients with IC secondary to idiopathic inflammatory myopathy (IIM‐IC ...
Yingxian Liu   +9 more
doaj   +1 more source

Myositis mimics

open access: yesIndian Journal of Rheumatology, 2021
Proximal muscle weakness in children, as well as adults, can be the presenting feature of a wide range of diseases including but not limited to the idiopathic inflammatory myopathies, muscle dystrophies, metabolic, endocrine, and drug-induced myopathies.
Sujata Ganguly   +3 more
doaj   +1 more source

Malignancy and idiopathic inflammatory myopathies

open access: yesNorth American Journal of Medical Sciences, 2013
Association between idiopathic inflammatory myopathies (IIMs) and malignancy is well known and has been extensively reported in the literature. However, in the recent years, several new studies were published allowing us to better understand the clinical characteristics and pathophysiology of cancer-associated IIMs.
Ungprasert, Patompong   +2 more
openaire   +3 more sources

Polymyositis Presenting With Nontraumatic Rhabdomyolysis and Dysphagia: A Case Report

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2022
Idiopathic inflammatory myopathies (IIMs) are a rare, heterogeneous group of diseases with a characteristic clinical presentation consisting of muscle inflammation and weakness.
Jonathan Aldrete MD   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy